(Q80841856)
Statements
The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine (English)
Mei Sheng Duh
Frederick Andermann
Pierre Emmanuel Paradis
Jennifer Weiner
Ranjani Manjunath
Pierre-Yves Crémieux